White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke.

Last updated: May 8, 2019
Sponsor: Pomeranian Medical University Szczecin
Overall Status: Completed

Phase

N/A

Condition

Cerebral Ischemia

Stroke

Dementia

Treatment

N/A

Clinical Study ID

NCT03944694
0012/84/03/19
  • Ages > 18
  • All Genders

Study Summary

The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age >18 years)

  • acute ischemic stroke

Exclusion

Exclusion Criteria:

  • hematology disorders

  • incomplete laboratory testing

  • no data regarding follow-up

Study Design

Total Participants: 1001
Study Start date:
June 30, 2015
Estimated Completion Date:
March 31, 2019

Study Description

Delirium is an acute brain disorder, potentially reversible, commonly occurring in patients with acute ischemic stroke. The pathomechanism of delirium is related to neuroinflammatory process and oxidative stress. Search for readily available diagnostic marker that will aid clinicians in early identification of delirium is an on-going process. The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).